Medtronic
Healthcare Company and Company
Heart devices jump-start MedtronicBy MATTHEW PERRONE and DAMIAN J. TROISE - Associated Press NEW YORK - Medtronic reported a surprising 59 percent boost in second-quarter profit Tuesday, as increased sales of implantable heart devices defied reports of weakening demand... In this article: Medtronic, Revenue, Thomson Reuters, St. Jude Medical, Boston Scientific Corp., and San Antonio |
-
Reuters | 15 hours ago
UPDATE 4-Medtronic earnings top estimates; raises outlook
...to analysts * Shares rise 5.9 percent (Recasts, adds CEO interview, conference call details) By Susan Kelly Medtronic Inc <MDT.N> posted better-than-expected quarterly results, outperforming rivals Boston Scientific Corp <BSX.N>...
In this article: Revenue, St Jude Medical, Boston Scientific Corp, and New York Stock Exchange
-
washingtonpost.com | 17 hours ago
Medtronic earnings top estimates; raises outlook
...Jeff Jonas said of the ICD sales, "They definitely gained some market share there." His firm owns Medtronic shares. Total revenue in the company's Cardiac Rhythm Disease Management division, which includes both ICDs and pacemakers,...
In this article: Revenue, Fiscal year, St Jude Medical, Boston Scientific Corp, and New York Stock Exchange
-
Reuters | 19 hours ago
Medtronic quarterly earnings top estimates
Medtronic Inc <MDT.N> said on Tuesday that quarterly earnings rose 59 percent on steady demand for its devices that protect against life-threatening heart rhythms, and it raised its fiscal-year forecast. Net income for the medical device...
In this article: Medtronic Inc and Minneapolis
-
AP Online | 1 day ago
Earnings Preview: Medtronic
...on Tuesday. The following is a summary of key developments and analyst opinion for the last period. OVERVIEW: Last week Medtronic said it had received a warning letter from the Food and Drug Administration about quality control problems at...
In this article: Revenue, Boston Scientific Corp., Food and Drug Administration, Thomson Reuters, St. Jude Medical, Wall Street, Washington, and Minnesota
-
Reuters | 6 days ago
BUY OR SELL-Is Medtronic immune to device sector turmoil?
...prospects By Susan Kelly In a medical device sector rocked by profit warnings from top names, investors are looking to Medtronic Inc <MDT.N> as an island of calm. While Boston Scientific <BSX.N> and St Jude Medical <STJ.N> shares...
In this article: Medtronic Inc, Chris Sullivan, First National Bank, St Jude Medical, Tax, U.S., and Writing's ON THE WALL
-
Reuters | 6 days ago
UPDATE 2-Medtronic gets FDA warning letter after inspection
* Has taken some actions to address FDA concerns * Shares down 51 cents to $39.69 (Adds detail, updates shares) Medtronic Inc. <MDT.N> confirmed on Wednesday it had received a warning letter from U.S. health regulators calling for...
In this article: Food and Drug Administration, CRM, Mounds View, Minnesota, St. Jude Medical, Boston Scientific, and New York Stock Exchange
-
washingtonpost.com | 6 days ago
Medtronic gets FDA warning on heart implant unit
...and the speed with which it informs the FDA of any issues. The agency also cited problems with Medtronic's quality control for suppliers. Medtronic is the world's largest medical device maker, and the cardiac rhythm disease management unit...
In this article: Food and Drug Administration, Minneapolis, Mounds View, Minn., and Minnesota
Trends
Loading...
More on Medtronic
Description from Wikipedia:
300px|right|thumb|Medtronic World Headquarters, [[Fridley, Minnesota (A suburb of Minneapolis).]]
thumb|right|Earl Bakken, founder of Medtronic
Medtronic, Inc. (NYSE: MDT), based in Minneapolis, Minnesota, is the world's largest medical technology company. Listed among Fortune 500 companies, Medtronic is a publicly traded company and is listed on the New York Stock Exchange under the symbol MDT. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and is credited with manufacturing the first wearable artificial pacemakers. However, they started off with much more modest intentions, acting as a repair company, servicing medical equipment in local hospitals. Medtronic's main competitors for cardiac devices are Boston Scientific and St. Jude Medical.
Medtronic followed a path familiar to technology historians, starting in a garage in northeast Minneapolis. The company expanded through the 1950s, mostly selling equipment built by other companies, but some custom hardware was also developed. The employees eventually came to know C. Walton Lillehei, a heart surgeon who was then at the University of Minnesota. Lillehei was frustrated with the pacemakers of the day, which relied on wall current to operate. This was extremely troublesome because power outages would cause patients to die.
Bakken built a small transistorized pacemaker that could be strapped to the body and powered by batteries. Work into this new field continued, producing an implantable pacemaker in 1960.
- Name:
- Medtronic, Inc.
- Location:
- Minneapolis, Minnesota|Northridge, California, USA
- Founded:
- 1949
- Stock Symbol:
- MDT
- Industry:
- Medical technology
- Key People:
- Bill Hawkins, Chairman & CEO
- Products:
- Medical devices
- Revenue:
- $14.599 Billion (2008)
- No. of Employees:
- 41,000
- Motto:
- "Alleviating Pain • Restoring Health • Extending Life"
Explore everything named Medtronic...